Beauty

Lululemon’s Proxy Fight Is Over. The Real Test Starts Now.

With its boardroom battle in the rearview, the activewear giant can finally focus on defending its relevance and figuring out its next growth engine as rivals chip away its category dominance.

Related posts

A Mid-Year M&A Check-In

Raven Ward

This Week: Another Tough Quarter for Kering

Raven Ward

Exclusive: Bridgepoint Group to Acquire Obagi Medical

Raven Ward